NEW YORK (GenomeWeb) – Celmatix's multi-gene panel test for reproductive health conditions, Fertilome, has been approved by New York State's Department of Health as a laboratory-developed test, the firm said today.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.